行情

DARE

DARE

Dare Bioscience
NASDAQ

实时行情|Nasdaq Last Sale

0.7500
-0.0350
-4.46%
已收盘, 17:57 11/14 EST
开盘
0.7700
昨收
0.7850
最高
0.7800
最低
0.6902
成交量
51.12万
成交额
--
52周最高
3.250
52周最低
0.6000
市值
1,251.26万
市盈率(TTM)
-0.7196
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DARE 新闻

  • 沪指微幅高开 美联储官员密集讲话
  • 新浪财经.17分钟前
  • 阿里巴巴15日正式启动香港上市
  • 新华网.1小时前
  • 沃尔玛Q3在线销售增长41% 与亚马逊战争全面开启?
  • 新浪财经-自媒体综合.1小时前
  • 英国未提名欧盟委员 欧盟料采取法律行动
  • 汇通网.1小时前

更多

所属板块

生物技术和医学研究
-0.05%
制药与医学研究
-0.27%

热门股票

名称
价格
涨跌幅

DARE 简况

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
展开

Webull提供Dare Bioscience Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。